HCV reinfection incidence among individuals treated for recent infection
- 27 December 2016
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 24 (5) , 359-370
Abstract
Summary: One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this analysis was to calculate the incidence of HCV reinfection among both HIV‐positive and HIV‐negative individuals treated for recent HCV infection (estimated infection duration n=120; 83% male; median age 36 years) was composed of HIV‐positive men‐who‐have‐sex‐with‐men (53%) and people who inject drugs (current 49%, ever 69%). Total follow‐up time at risk was 135 person‐years (median 1.08 years, range 0.17, 2.53). Ten cases of HCV reinfection were identified, for an incidence of 7.4 per 100 py (95% CI 4.0, 13.8). Reinfection incidence was significantly higher among participants who reported injection drug use at end of or post‐treatment, irrespective of HIV status (15.5 per 100 py, 95% CI 7.8, 31.1). In adjusted analysis, factors associated with reinfection were older age (aIRR 5.3, 95% CI 1.15, 51.5, P=.042) and injection drug use at end of or post‐treatment (aIRR 7.9, 95% CI 1.6, 77.2, P=.008). High reinfection incidence following treatment for recent HCV infection in individuals with ongoing risk behaviour emphasizes the need for post‐treatment surveillance, harm reduction strategies and education in at‐risk populations.Keywords
Funding Information
- National Institute on Drug Abuse (R01DA015999)
- Gilead Sciences
- National Health and Medical Research Council
- AbbVie
- Bristol-Myers Squibb
- Merck
- ViiV Healthcare
- Roche
- Vertex Pharmaceuticals
- Department of Health, Disability and Ageing
- National Institutes of Health
This publication has 60 references indexed in Scilit:
- Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 InfectionsGastroenterology, 2016
- Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventionsHepatology, 2016
- Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsDrug and Alcohol Dependence, 2016
- Hepatitis C virus treatment as prevention in people who inject drugsCurrent Opinion in Infectious Diseases, 2015
- Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programsInternational Journal of Drug Policy, 2015
- Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis CInternational Journal of Drug Policy, 2015
- The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering AnalysisPLOS ONE, 2015
- Short Duration Response-Guided Treatment is Effective for Most Individuals with Recent Hepatitis C Infection: The ATAHC II and DARE-C I StudiesAntiviral Therapy, 2015
- The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study DesignThe Journal of Infectious Diseases, 2012
- Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug UsersClinical Infectious Diseases, 2004